Shahzad Malik - Jun 17, 2021 Form 4 Insider Report for Acutus Medical, Inc. (AFIB)

Role
Director
Signature
/s/ Tom Sohn as attorney-in-fact for Shahzad Malik
Stock symbol
AFIB
Transactions as of
Jun 17, 2021
Transactions value $
$0
Form type
4
Date filed
6/22/2021, 05:11 PM

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AFIB Common Stock Award $0 +1.8K +81.01% $0.00 4.02K Jun 17, 2021 Direct F1
holding AFIB Common Stock 65.4K Jun 17, 2021 See footnote F2
holding AFIB Common Stock 1.55M Jun 17, 2021 See footnote F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AFIB Stock Options (Right to Buy) Award $0 +7.02K $0.00 7.02K Jun 17, 2021 Common Stock 7.02K $16.66 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each annual restricted stock unit ("Annual RSU") will be scheduled to vest as to all of the shares of Common Stock ("Shares") subject to such Annual RSU on the first anniversary of the date of grant of such Annual RSU, if on such date the Reporting person has remained in continuous service as a director
F2 These shares are held by Advent Life Sciences LLP ("Advent"). The Reporting Person is a general partner of Advent, and disclaims beneficial ownership of the securities held by Advent except to the extent of his indirect pecuniary interest therein.
F3 These shares are held by Advent Life Sciences Fund I LP. Advent is the general partner of Advent Life Sciences Fund II LP and the Reporting Person is a general partner of Advent. The Reporting Person disclaims beneficial ownership of the securities held by Advent Life Sciences Fund II LP except to the extent of his indirect pecuniary interest therein.
F4 Each annual stock option (the "Annual Option") will be scheduled to vest and become exercisable as to all of the Shares subject to such Annual Option on the first anniversary of the date of grant of such Annual Option, if on such date the Reporting Person has remained in continuous service as a director.